Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli.
D000328:Adult; D000368:Aged; D000707:Anaphylaxis; D001215:Asparaginase / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D001216:Asparagine / Q000097:blood; D001224:Aspartic Acid / Q000097:blood; D003630:Daunorubicin / Q000627:therapeutic use; D004342:Drug Hypersensitivity; D004885:Erwinia / Q000201:enzymology*; D004926:Escherichia coli / Q000201:enzymology*; D005260:Female; D006207:Half-Life; D006801:Humans; D007945:Leukemia, Lymphoid / Q000097:blood / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D001224:Aspartic Acid; D014750:Vincristine; D001216:Asparagine; D015122:Mercaptopurine; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin